Quinn Anthony G.

CIK 00015322194 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001532219

Recent Transactions

50 trades

Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2025-06-04+30,000→ 30,000 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2025-01-13$0.97/sh+85,000→ 299,286 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2025-01-10$0.96/sh+125,791→ 214,286 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2024-06-06+60,000→ 60,000 total
Purchase
Generation Bio Co.$GBIO
Common Stock
2023-12-01$1.41/sh+88,495→ 88,495 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2023-06-08+25,000→ 25,000 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2022-06-09+19,200→ 19,200 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2022-03-16$2.34/sh+80,079→ 550,540 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2022-03-15$1.86/sh+42,417→ 473,461 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2022-03-14$1.93/sh+67,472→ 431,044 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2022-03-11$2.06/sh+34,777→ 363,572 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2022-02-17+350,000→ 350,000 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-12-10$3.75/sh+10,526→ 328,795 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-12-09$3.70/sh+43,108→ 318,269 total
Gift
Generation Bio Co.$GBIO
Common Stock
2021-10-28+72,837→ 72,837 total
Gift
Generation Bio Co.$GBIO
Common Stock
2021-10-28−72,837→ 0 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-20−10,000→ 328,795 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-20+10,000→ 208,845 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-18−23,809→ 328,795 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-18+23,809→ 208,845 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-14+175,036→ 208,845 total
Gift
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-10-14−175,036→ 328,795 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-30+15,000→ 15,000 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2021-06-09+15,000→ 15,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2021-02-17+330,000→ 330,000 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2020-06-30+15,000→ 15,000 total
Conversion
Generation Bio Co.$GBIO
Series C Preferred Stock
2020-06-16−53,654→ 0 total
Conversion
Generation Bio Co.$GBIO
Common Stock
2020-06-16+30,376→ 72,837 total
Award
Generation Bio Co.$GBIO
Stock Option (right to buy)
2020-06-11+52,000→ 52,000 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2020-04-30$4.75/sh+165,000→ 538,469 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2020-02-14+301,000→ 301,000 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2019-10-04−17,603→ 119,914 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2019-10-04−662→ 0 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-10-04$5.46/sh+662→ 354,305 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-10-04$6.31/sh+17,603→ 371,908 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-06-14$6.23/sh+5,282→ 353,643 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-06-13$6.17/sh+14,406→ 348,361 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-06-12$6.11/sh+12,217→ 333,955 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-22$6.86/sh+3,809→ 321,738 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-21$6.89/sh+13,794→ 317,929 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-20$6.55/sh+8,989→ 304,135 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-17$6.65/sh+6,218→ 295,146 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-16$6.83/sh+5,520→ 288,928 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-05-15$6.76/sh+6,256→ 283,408 total
Conversion
Kaleido Biosciences, Inc.
Series B Preferred Stock
2019-03-04−25,707→ 0 total
Conversion
Kaleido Biosciences, Inc.
Common Stock
2019-03-04+12,853→ 31,603 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2019-02-28+280,000→ 280,000 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2019-02-15$7.10/sh+719→ 277,152 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2019-02-06−1,323→ 662 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2019-02-06−7,433→ 137,517 total

Companies

Recent Filings

Address

C/O SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520

LEXINGTON, MA, 02421

View on SEC.gov